These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9120899)

  • 1. What target pralidoxime concentration?
    Dawson A; Buckley N; Whyte I
    J Toxicol Clin Toxicol; 1997; 35(2):227-30. PubMed ID: 9120899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antidose therapy for organophosphate poisoning].
    Iseki K
    Chudoku Kenkyu; 2008 Apr; 21(2):151-9. PubMed ID: 18516940
    [No Abstract]   [Full Text] [Related]  

  • 3. Nerve agent toxicology.
    Wood SP
    JEMS; 2003 Dec; 28(12):16; author reply 16. PubMed ID: 14702965
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning.
    Schexnayder S; James LP; Kearns GL; Farrar HC
    J Toxicol Clin Toxicol; 1998; 36(6):549-55. PubMed ID: 9776957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier.
    Sakurada K; Matsubara K; Shimizu K; Shiono H; Seto Y; Tsuge K; Yoshino M; Sakai I; Mukoyama H; Takatori T
    Neurochem Res; 2003 Sep; 28(9):1401-7. PubMed ID: 12938863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular kinetics and dosage regimens for pralidoxime in buffalo calves (Bubalus bubalis).
    Srivastava AK; Malik JK
    Vet Res Commun; 2001 May; 25(4):301-9. PubMed ID: 11432431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of UV spectroscopic, chromatographic, and electrophoretic methods for the cholinesterase reactivating antidote pralidoxime (2-PAM).
    John H; Blum MM
    Drug Test Anal; 2012; 4(3-4):179-93. PubMed ID: 21953823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition kinetics of 2-pyridine aldoxime methochloride in Bubalus bubalis.
    Srivastava AK; Malik JK
    J Vet Pharmacol Ther; 1989 Mar; 12(1):103-8. PubMed ID: 2704055
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposition kinetics and urinary excretion of 2-pyridine aldoxime methiodide in sheep.
    Srivastava AK; Malik JK
    Vet Rec; 1989 Oct; 125(17):436-7. PubMed ID: 2588454
    [No Abstract]   [Full Text] [Related]  

  • 10. Biodistribution and plasma protein binding of 2-formyl-1-methyl pyridinium methiodide (2-PAM) in sheep (Ovis aries).
    Srivastava AK; Malik JK
    Indian J Exp Biol; 1988 Aug; 26(8):643-4. PubMed ID: 3198165
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of continuous infusion of pralidoxime for treatment of organophosphate poisoning in children.
    Farrar HC; Wells TG; Kearns GL
    J Pediatr; 1990 Apr; 116(4):658-61. PubMed ID: 2319410
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the therapeutic effect of 2-pyridine aldoxime methiodide (2-PAM) in mammals following organophosphorus compound-poisoning (report III): distribution and antidotal effect of 2-PAM in rats.
    Uehara S; Hiromori T; Isobe N; Suzuki T; Kato T; Miyamoto J
    J Toxicol Sci; 1993 Nov; 18(4):265-75. PubMed ID: 8295230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is PAM an effective antidote for organophosphate poisoning? There is no evidence that PAM is effective in acute organophosphorus poisoning].
    Tase C
    Chudoku Kenkyu; 2010 Mar; 23(1):36-40. PubMed ID: 20380320
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers.
    Medicis JJ; Stork CM; Howland MA; Hoffman RS; Goldfrank LR
    J Toxicol Clin Toxicol; 1996; 34(3):289-95. PubMed ID: 8667466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy for changing plasma pralidoxime kinetics and, perhaps, effect in organophosphorus insecticide poisoning.
    Eddleston M; Buckley NA
    Crit Care Med; 2011 Apr; 39(4):908-9. PubMed ID: 21613850
    [No Abstract]   [Full Text] [Related]  

  • 16. Pralidoxime--the gold standard of acetylcholinesterase reactivators--reactivation in vitro efficacy.
    Kuca K; Hrabinova M; Soukup O; Tobin G; Karasova J; Pohanka M
    Bratisl Lek Listy; 2010; 111(9):502-4. PubMed ID: 21180265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of acetylcholinesterase reactivators 2PAM-I, TMB4 and R665 in rats submitted to organophosphate poisoning.
    Garrigue H; Maurizis JC; Madelmont JC; Nicolas C; Meyniel JM; Louvel A; Demerseman P; Sentenac-Roumanou H; Veyre A
    Xenobiotica; 1991 May; 21(5):583-95. PubMed ID: 1949891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pralidoxime for reducing nicotinic cholinergic morbidity in organophosphate poisoning.
    Patial RK; Kapoor D
    J Assoc Physicians India; 1998 Jul; 46(7):668. PubMed ID: 12152866
    [No Abstract]   [Full Text] [Related]  

  • 19. Respiratory arrest caused by accidental rapid pralidoxime infusion.
    Jeong TO; Lee JB; Jin YH; Yoon JC
    Clin Toxicol (Phila); 2015 May; 53(4):412. PubMed ID: 25684397
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs).
    Gallagher E; Minn I; Chambers JE; Searson PC
    Fluids Barriers CNS; 2016 Jul; 13(1):10. PubMed ID: 27396356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.